Seven & i Holdings Co., Ltd. (TYO:3382) is reportedly set to reject a $47 billion acquisition offer from Canada’s Alimentation Couche Tard Inc. (TSX:ATD), according to Japan’s Yomiuri newspaper. The retail giant, best known for its 7-Eleven convenience stores, will instead focus on boosting its corporate value independently.
The deal could face antitrust challenges in the U.S., adding to Seven & i’s hesitations. The rejection comes shortly after a $58 billion bid to take the company private—led by the founding Ito family—collapsed due to funding issues.
Meanwhile, reports indicate that director Stephen Dacus is preparing to replace Ryuichi Isaka as president, marking a significant leadership shift.
Although Seven & i initially signaled a willingness to consider Couche Tard’s proposal, it now aims to enhance shareholder value through internal strategies. However, it remains unclear what steps the company will take to achieve this goal.
With major acquisition offers falling through, Seven & i’s future direction will be closely watched by investors and industry analysts.


TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 



